Learn how adverse event rates are calculated in clinical trials, why simple percentages can mislead, and how the FDA now requires exposure-adjusted methods like EAIR to reveal true drug safety profiles.
Learn how adverse event rates are calculated in clinical trials, why simple percentages can mislead, and how the FDA now requires exposure-adjusted methods like EAIR to reveal true drug safety profiles.